CoChat

Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Breast cancers are highly heterogeneous and their metastatic potential and response to therapeutic drugs is difficult to predict. A tool that could accurately gauge tumour invasiveness and drug response would provide a valuable addition to the oncologist’s arsenal. We have developed a 3-dimensional (3D) culture model that recapitulates the stromal environment of breast cancers by generating anisotropic (directional) collagen scaffolds seeded with adipocytes and culturing tumour fragments therein. Analysis of tumour cell invasion in the presence of various therapeutic drugs, by immunofluorescence microscopy coupled with an optical clearing technique, demonstrated the utility of this approach in determining both the rate and capacity of tumour cells to migrate through the stroma while shedding light also on the mode of migration. Furthermore, the response of different murine mammary tumour types to chemotherapeutic drugs could be readily quantified.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-30107-3

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 ET-SIM (Engineered Tumour-Stroma Interaction Model) and tumour fragment culture strategy. (a) Scanning electron micrograph (SEM) of anisotropic collagen scaffold (scaffold nucleation point marked with a white dotted line) with directional collagen pores and schematic of ET-SIM (Engineered Tumour-Stroma Interaction Model) culture. (b) Whole mount immunostained ET-SIM culture imaged using second harmonic generation (SHG, collagen I, grey) and two photon fluorescence (2pf) microscopy z-stacks. Nuclei are stained with green fluorescent dye SYTO16 (green). Lipids are stained with anti-perilipin (red). Z-stacks are displayed as maximum intensity projections (left) and individual magnified z-sections (i-iii, right). (c) Whole mount immunostained ET-SIM culture imaged using SHG and 2pf microscopy z-stacks. Nuclei are stained with green fluorescent dye SYTO16 (green). Basement membrane proteins are stained with anti-collagen IV (red, left) and anti-laminin (red, right). Z-stacks are displayed as maximum intensity projections. Magnified maximum intensity projections shown in (i) and (ii). (d) Schematic of tumour fragment and ET-SIM co-culture.
Figure 1 ET-SIM (Engineered Tumour-Stroma Interaction Model) and tumour fragment culture strategy. (a) Scanning electron micrograph (SEM) of anisotropic collagen scaffold (scaffold nucleation point marked with a white dotted line) with directional collagen pores and schematic of ET-SIM (Engineered Tumour-Stroma Interaction Model) culture. (b) Whole mount immunostained ET-SIM culture imaged using second harmonic generation (SHG, collagen I, grey) and two photon fluorescence (2pf) microscopy z-stacks. Nuclei are stained with green fluorescent dye SYTO16 (green). Lipids are stained with anti-perilipin (red). Z-stacks are displayed as maximum intensity projections (left) and individual magnified z-sections (i-iii, right). (c) Whole mount immunostained ET-SIM culture imaged using SHG and 2pf microscopy z-stacks. Nuclei are stained with green fluorescent dye SYTO16 (green). Basement membrane proteins are stained with anti-collagen IV (red, left) and anti-laminin (red, right). Z-stacks are displayed as maximum intensity projections. Magnified maximum intensity projections shown in (i) and (ii). (d) Schematic of tumour fragment and ET-SIM co-culture.CC BY · PubMed Central
Figure 2 Wnt1 driven tumour fragment co-culture and tumour cell analysis. (a) Immunohistochemistry (IHC) of Wnt1 tumour fragment (top), seeded into the nucleation point (white dotted line) of anisotropic collagen scaffolds/ET-SIM (bottom), cultured for 72 hours, embedded in paraffin and transversely sectioned (diagram, top left). A tile scan of the area containing the tumour fragment and the top of the scaffold is shown in (a). Magnified images of the free edge of the tumour fragment (a, white box) is shown in (i-iv). DNA is marked using Hoechst (blue). Luminal tumour cells are marked with anti-β-catenin (red, i-iii) and E-cadherin (green, iv). Lumen marked as*. Basal tumour cells are marked with anti-cytokeratin-14+ (K14, green, i), anti-α-smooth muscle actin+ (αSMA, green, ii) and anti-p63 (nuclear, green, iii). Apoptotic cells are marked with anti-cleaved caspase-3 (CC3, red, iv). (b) Using the same markers as in (a), the edge of the tumour in contact with an anisotropic collagen scaffold (b, white box) and (i-iv), shows collective migration of K14+/αSMA+/p63+ basal and β-catenin+/E-cadherin+ luminal cells. Arrowheads in (iv) show p63+ nuclei.
Figure 2 Wnt1 driven tumour fragment co-culture and tumour cell analysis. (a) Immunohistochemistry (IHC) of Wnt1 tumour fragment (top), seeded into the nucleation point (white dotted line) of anisotropic collagen scaffolds/ET-SIM (bottom), cultured for 72 hours, embedded in paraffin and transversely sectioned (diagram, top left). A tile scan of the area containing the tumour fragment and the top of the scaffold is shown in (a). Magnified images of the free edge of the tumour fragment (a, white box) is shown in (i-iv). DNA is marked using Hoechst (blue). Luminal tumour cells are marked with anti-β-catenin (red, i-iii) and E-cadherin (green, iv). Lumen marked as*. Basal tumour cells are marked with anti-cytokeratin-14+ (K14, green, i), anti-α-smooth muscle actin+ (αSMA, green, ii) and anti-p63 (nuclear, green, iii). Apoptotic cells are marked with anti-cleaved caspase-3 (CC3, red, iv). (b) Using the same markers as in (a), the edge of the tumour in contact with an anisotropic collagen scaffold (b, white box) and (i-iv), shows collective migration of K14+/αSMA+/p63+ basal and β-catenin+/E-cadherin+ luminal cells. Arrowheads in (iv) show p63+ nuclei.CC BY · PubMed Central
Figure 3 TUBO tumour fragment co-culture and tumour cell analysis in ET-SIM. (a) Immunohistochemistry (IHC) of TUBO (Her2-neu overexpressing) tumour fragments (top), seeded into the nucleation point (white dotted line) of anisotropic collagen scaffolds (bottom) with 3T3-L1 adipocytes (insert labelled 3T3-L1), cultured for 72 hours, embedded in paraffin and transversely sectioned (diagram, left). The area shown is a tile scan of the tumour fragment and the top of the scaffold (diagram, left). DNA is marked using Hoechst (blue). TUBO tumour cells are marked with anti-E-cadherin (green). Apoptotic cells are marked with anti-cleaved caspase-3 (CC3, red). Magnified images of migratory TUBO cells are shown in inserts (i-iv). (b) IHC of TUBO cells within the bulk of the seeded tumour fragment. TUBO cells are marker with anti-cytokeratin-18 (K18, green) and epithelial-to-mesenchymal (EMT) transition marker anti-vimentin (red). Stochastic expression of vimentin is localised around one edge of TUBO cell nuclei (arrowheads). (c) IHC of migratory TUBO tumour cells within the anisotropic collagen scaffold with similar stochastic vimentin expression in K18+ TUBO cells (arrowhead).
Figure 3 TUBO tumour fragment co-culture and tumour cell analysis in ET-SIM. (a) Immunohistochemistry (IHC) of TUBO (Her2-neu overexpressing) tumour fragments (top), seeded into the nucleation point (white dotted line) of anisotropic collagen scaffolds (bottom) with 3T3-L1 adipocytes (insert labelled 3T3-L1), cultured for 72 hours, embedded in paraffin and transversely sectioned (diagram, left). The area shown is a tile scan of the tumour fragment and the top of the scaffold (diagram, left). DNA is marked using Hoechst (blue). TUBO tumour cells are marked with anti-E-cadherin (green). Apoptotic cells are marked with anti-cleaved caspase-3 (CC3, red). Magnified images of migratory TUBO cells are shown in inserts (i-iv). (b) IHC of TUBO cells within the bulk of the seeded tumour fragment. TUBO cells are marker with anti-cytokeratin-18 (K18, green) and epithelial-to-mesenchymal (EMT) transition marker anti-vimentin (red). Stochastic expression of vimentin is localised around one edge of TUBO cell nuclei (arrowheads). (c) IHC of migratory TUBO tumour cells within the anisotropic collagen scaffold with similar stochastic vimentin expression in K18+ TUBO cells (arrowhead).CC BY · PubMed Central
Figure 4 Analysis of tumour cell migration and response to pathway inhibitors (72 hours). Comparison of Wnt1 tumour cell migratory distance, from the anisotropic collagen scaffold nucleation point to within the scaffold, after 72 hours culture in the absence (a) or presence (b) of differentiated 3T3-L1 cells (known as ET-SIM), with/without pathway inhibitors ROCKi, GM6001 and Canertinib, all statistically compared to DMSO (vehicle control). The total number of migratory Wnt1 tumour cells within the scaffolds, in the absence (c) or presence (d) of differentiated 3T3-L1 cells (known as ET-SIM), with/without the pathway inhibitors ROCKi, GM6001 and Canertinib compared to DMSO (vehicle control). The following statistical analyses were applied: non-parametric unpaired/matching Kruskal-Wallis ANOVA with a Geisser-greenhouse correction combined with a Dunn’s multiple comparison test, *p < 0.05, ****p < 0.0001. Sample size n = 4.
Figure 4 Analysis of tumour cell migration and response to pathway inhibitors (72 hours). Comparison of Wnt1 tumour cell migratory distance, from the anisotropic collagen scaffold nucleation point to within the scaffold, after 72 hours culture in the absence (a) or presence (b) of differentiated 3T3-L1 cells (known as ET-SIM), with/without pathway inhibitors ROCKi, GM6001 and Canertinib, all statistically compared to DMSO (vehicle control). The total number of migratory Wnt1 tumour cells within the scaffolds, in the absence (c) or presence (d) of differentiated 3T3-L1 cells (known as ET-SIM), with/without the pathway inhibitors ROCKi, GM6001 and Canertinib compared to DMSO (vehicle control). The following statistical analyses were applied: non-parametric unpaired/matching Kruskal-Wallis ANOVA with a Geisser-greenhouse correction combined with a Dunn’s multiple comparison test, *p < 0.05, ****p < 0.0001. Sample size n = 4.CC BY · PubMed Central
Figure 5 Wnt1 tumour cells treated with ROCKi exhibit increased migration. Immunohistochemistry analysis of Wnt1 tumour fragment seeded into an empty anisotropic collagen scaffold nucleation point (white dotted line), cultured for 10 days then embedded in paraffin and transversely sectioned. Migratory cancer cells are marked with αSMA (green) and β-catenin (red) and DNA is marked with Hoechst. Panel (a) is in the presence of DMSO (vehicle control) for 10 days and (i) shows migratory cells at <500 µm near the nucleation point. Panel (b) is in the presence of ROCKi (Y-27632) for 10 days. (i) and (ii) show migratory cells at distances at >500 µm. (iii) and (iv) show migratory cells at <500 µm near the nucleation point.
Figure 5 Wnt1 tumour cells treated with ROCKi exhibit increased migration. Immunohistochemistry analysis of Wnt1 tumour fragment seeded into an empty anisotropic collagen scaffold nucleation point (white dotted line), cultured for 10 days then embedded in paraffin and transversely sectioned. Migratory cancer cells are marked with αSMA (green) and β-catenin (red) and DNA is marked with Hoechst. Panel (a) is in the presence of DMSO (vehicle control) for 10 days and (i) shows migratory cells at <500 µm near the nucleation point. Panel (b) is in the presence of ROCKi (Y-27632) for 10 days. (i) and (ii) show migratory cells at distances at >500 µm. (iii) and (iv) show migratory cells at <500 µm near the nucleation point.CC BY · PubMed Central
Figure 6 Analysis of tumour cell migration and response to pathway inhibitors (10 days). Comparison of Wnt1 tumour cell migratory distance, from the anisotropic collagen scaffold nucleation point to within the scaffold, after 72 hours culture in the absence (a) or presence (b) of differentiated 3T3-L1 cells (known as ET-SIM), with/without pathway inhibitors ROCKi, GM6001 and Canertinib, all statistically compared to DMSO (vehicle control). The total number of migratory Wnt1 tumour cells within the scaffolds, in the absence (c) or presence (d) of differentiated 3T3-L1 cells (known as ET-SIM), with/without the pathway inhibitors ROCKi, GM6001 and Canertinib compared to DMSO (vehicle control). The following statistical analyses were applied: non-parametric unpaired/matching Kruskal-Wallis ANOVA with a Geisser-greenhouse correction combined with a Dunn’s multiple comparison test, *p < 0.05, ****p < 0.0001. Sample size n = 4.
Figure 6 Analysis of tumour cell migration and response to pathway inhibitors (10 days). Comparison of Wnt1 tumour cell migratory distance, from the anisotropic collagen scaffold nucleation point to within the scaffold, after 72 hours culture in the absence (a) or presence (b) of differentiated 3T3-L1 cells (known as ET-SIM), with/without pathway inhibitors ROCKi, GM6001 and Canertinib, all statistically compared to DMSO (vehicle control). The total number of migratory Wnt1 tumour cells within the scaffolds, in the absence (c) or presence (d) of differentiated 3T3-L1 cells (known as ET-SIM), with/without the pathway inhibitors ROCKi, GM6001 and Canertinib compared to DMSO (vehicle control). The following statistical analyses were applied: non-parametric unpaired/matching Kruskal-Wallis ANOVA with a Geisser-greenhouse correction combined with a Dunn’s multiple comparison test, *p < 0.05, ****p < 0.0001. Sample size n = 4.CC BY · PubMed Central
Figure 7 Optical clearing of TUBO tumours in anisotropic collagen scaffolds and cancer therapeutic testing. (a) Transmission stereoscopic images of uncleared and optically cleared (CUBIC) anisotropic collagen scaffold and TUBO (Her2-neu overexpressing) tumour from a top down view. (b) Fluorescent stereoscopic images of TUBO tumour fragments in scaffolds, cultured for 10 days with/without adipocytes (3T3-L1), treated with DMSO (control), ROCKi (Y-27632), GM6001 or Canertinib, CUBIC cleared and immunostained for E-cadherin (green) and Her2 (not shown). Cell nuclei are stained with DAPI (blue). Clusters of cancer cells that have migrated away from the central tumour fragment are marked with arrowheads. (c,d) Large tile scan z-stack (1 mm depth) confocal microscopy images of ROCKi treated TUBO tumour fragments in anisotropic collagen scaffolds without/with adipocytes (3T3-L1), cleared and stained as described in (b) with DAPI (blue), E-cadherin (green) and Her2 (red). (i) and (ii) show magnified images of migratory clusters of Her2 and E-cadherin positive cells. (e) Quantification of the number of tumour/scaffolds that contain one or more visible migratory cell clusters. (f,g) Large tile scan z-stack (1 mm depth) confocal microscopy images of Canertinib treated TUBO tumour fragments in anisotropic collagen scaffolds without/with adipocytes (3T3-L1), cleared and stained as described in (b) with DAPI (blue), E-cadherin (green) and Her2 (red). (i) and (ii) show few non-migratory E-cadherin and Her2 cells seen in the seeded tumour fragment. No migratory cells were observed in the scaffold with Canertinib treatment at this magnification.
Figure 7 Optical clearing of TUBO tumours in anisotropic collagen scaffolds and cancer therapeutic testing. (a) Transmission stereoscopic images of uncleared and optically cleared (CUBIC) anisotropic collagen scaffold and TUBO (Her2-neu overexpressing) tumour from a top down view. (b) Fluorescent stereoscopic images of TUBO tumour fragments in scaffolds, cultured for 10 days with/without adipocytes (3T3-L1), treated with DMSO (control), ROCKi (Y-27632), GM6001 or Canertinib, CUBIC cleared and immunostained for E-cadherin (green) and Her2 (not shown). Cell nuclei are stained with DAPI (blue). Clusters of cancer cells that have migrated away from the central tumour fragment are marked with arrowheads. (c,d) Large tile scan z-stack (1 mm depth) confocal microscopy images of ROCKi treated TUBO tumour fragments in anisotropic collagen scaffolds without/with adipocytes (3T3-L1), cleared and stained as described in (b) with DAPI (blue), E-cadherin (green) and Her2 (red). (i) and (ii) show magnified images of migratory clusters of Her2 and E-cadherin positive cells. (e) Quantification of the number of tumour/scaffolds that contain one or more visible migratory cell clusters. (f,g) Large tile scan z-stack (1 mm depth) confocal microscopy images of Canertinib treated TUBO tumour fragments in anisotropic collagen scaffolds without/with adipocytes (3T3-L1), cleared and stained as described in (b) with DAPI (blue), E-cadherin (green) and Her2 (red). (i) and (ii) show few non-migratory E-cadherin and Her2 cells seen in the seeded tumour fragment. No migratory cells were observed in the scaffold with Canertinib treatment at this magnification.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 38

Metadata

Authors
Hume, R. D., Pensa, S., Brown, E. J., Kreuzaler, P. A., Hitchcock, J., Husmann, A., Campbell, J. J., Lloyd-Thomas, A. O., Cameron, R. E., & Watson, C. J.
Affiliations
University of Cambridge (GB)
Corresponding author
Watson, Christine J.
Venue
Scientific Reports
Published
2018-08-23
Volume
8
Issue
1
Pages
12658-12658
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2885206766
Cited by
37
References
56
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 7 · 2020: 5 · 2019: 3
FWCI
2.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • Queen Mary University of London
  • National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/K001655/1)
  • National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/K001655/1)
  • Medical Research Council (MR/K011014/1, MR/N022963/1)
  • FP7 Ideas: European Research Council (320598)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
breast cancer, tumor invasion, chemosensitivity, 3D collagen scaffold, adipocytes, tumor microenvironment, tumor stroma, tumor cell migration, optical tissue clearing, 3D culture models
MeSH terms
Animals, Cell Movement, Collagen, Female, Humans, Immunohistochemistry, Mice, Inbred BALB C, Microscopy, Fluorescence, Adipocytes, Microscopy, Confocal, Tissue Engineering, 3T3-L1 Cells, Mice, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds. https://app.cochat.ai/papers/10.1038/s41598-018-30107-3
The paper
Hume, R. D., Pensa, S., Brown, E. J., Kreuzaler, P. A., Hitchcock, J., Husmann, A., Campbell, J. J., Lloyd-Thomas, A. O., Cameron, R. E., & Watson, C. J. (2018). Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds. Scientific Reports. https://doi.org/10.1038/s41598-018-30107-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.